The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of toxicities of target therapy phase I and II trials on glioblastoma multiforme patients treated by curative radiotherapy: A meta-analysis.
Marcos Antonio Santos
No relevant relationships to disclose
Delphine Lefeuvre
No relevant relationships to disclose
Gwenael Le Teuff
No relevant relationships to disclose
Damien Bouda
No relevant relationships to disclose
Céline Bourgier
No relevant relationships to disclose
Julien Domont
No relevant relationships to disclose
Frederic Dhermain
No relevant relationships to disclose
Jean-Charles Soria
No relevant relationships to disclose
Eric Deutsch
No relevant relationships to disclose
Jean-Pierre Pignon
No relevant relationships to disclose